Detalhe da pesquisa
1.
Activation of a cGAS-STING-mediated immune response predicts response to neoadjuvant chemotherapy in early breast cancer.
Br J Cancer
; 126(2): 247-258, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34728791
2.
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning.
Gut
; 70(3): 544-554, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32690604
3.
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma.
Gut
; 68(11): 1918-1927, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30852560
4.
In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer.
Clin Cancer Res
; 27(1): 288-300, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33028592
5.
ATM Kinase Inhibition Preferentially Sensitises PTEN-Deficient Prostate Tumour Cells to Ionising Radiation.
Cancers (Basel)
; 13(1)2020 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33396656
6.
Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c Trial.
J Clin Oncol
; 37(36): 3484-3492, 2019 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31657982
7.
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer.
J Natl Cancer Inst
; 109(1)2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27707838
8.
Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology.
Eur Urol
; 72(4): 509-518, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28408174
9.
When the guardian becomes the enemy: Targeting ATM in PTEN-deficient cancers.
Mol Cell Oncol
; 3(1): e1053595, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27308567
10.
The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif.
Biochem J
; 379(Pt 2): 301-7, 2004 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14711368
11.
Mechanistic Rationale to Target PTEN-Deficient Tumor Cells with Inhibitors of the DNA Damage Response Kinase ATM.
Cancer Res
; 75(11): 2159-65, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25870146
12.
STAT3 regulated ARF expression suppresses prostate cancer metastasis.
Nat Commun
; 6: 7736, 2015 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26198641
13.
Identification and validation of an anthracycline/cyclophosphamide-based chemotherapy response assay in breast cancer.
J Natl Cancer Inst
; 106(1): djt335, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24402422
14.
Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma.
Eur Urol
; 64(2): 177-88, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22939387
15.
Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue.
J Clin Oncol
; 29(35): 4620-6, 2011 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22067406
16.
Erratum: STAT3 regulated ARF expression suppresses prostate cancer metastasis.
Nat Commun
; 6: 8802, 2015 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26499136
17.
Interfacial kinetic analysis of the tumour suppressor phosphatase, PTEN: evidence for activation by anionic phospholipids.
Biochem J
; 371(Pt 3): 947-55, 2003 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12534371